Literature DB >> 11268762

[Subthreshold psychological disorders].

H Helmchen1.   

Abstract

Subthreshold psychic disorders are mild, masked, atypical, or intense but brief psychopathological syndromes below the threshold of standardized diagnoses. They indicate beginning, intermittent, or residual states of well-known psychic disorders or ("comorbid") syndromes associated to other psychic or somatic disorders or possibly partially morbid states by themselves. At least the subthreshold depressions and anxiety disorders are more than twice as frequent as specified diagnosable psychic disorders and have serious consequences with regard to both individual suffering and cost. Primarily they are a problem for primary medical care. It is mainly up to the general practitioner to recognise beginning or residual psychic disorders underlying disturbed well-being or uneasiness in order to treat them preventively or curatively or to co-treat such comorbid states in somatic diseases. Open questions of research and possible consequences for health policy are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11268762     DOI: 10.1007/s001150050737

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

1.  [Person. Personality. Personality disorder?].

Authors:  H Sass
Journal:  Nervenarzt       Date:  2002-03       Impact factor: 1.214

2.  [Defining quality in psychiatric care].

Authors:  W Rössler
Journal:  Nervenarzt       Date:  2003-06-11       Impact factor: 1.214

3.  [Epidemiology of mental health care].

Authors:  M Jäger; W Rössler
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

Review 4.  [Psychopathology in the social context].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

5.  [Care differences in a consultation and liaison service].

Authors:  J Valdés-Stauber; S Bachthaler
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

Review 6.  Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.

Authors:  Siegfried Kasper; Markus Gastpar; Walter E Müller; Hans-Peter Volz; Hans-Jürgen Möller; Angelika Dienel; Sandra Schläfke
Journal:  Wien Med Wochenschr       Date:  2010-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.